Table 1.
Demographics of patients.
| Characteristic (n = 153) | n | |
|---|---|---|
| Gender | Male | 140 (91.5%) |
| Female | 13 (8.5%) | |
| Age(years) | Range | 40–85 |
| Median | 63 | |
| Pathology | Adenocarcinoma | 28 (18.3%) |
| Squamous cell carcinoma | 93 (60.8%) | |
| Othersa | 32 (20.9%) | |
| Stage | IIIA | 55 (35.9%) |
| IIIB | 98 (64.1%) | |
| Smoking history | Yes | 94 (61.4%) |
| No | 59 (38.6) | |
| Tumor location | Upper lobe | 87 (56.9%) |
| Middle lobe | 29 (18.9%) | |
| Lower lobe | 37 (24.2%) | |
| Chemotherapy | Concurrent | 22 (14.4%) |
| Sequence 1b | 123 (80.4%) | |
| Sequence 2c | 8 (5.2%) | |
| RP Graded | 0–1 | 120 (78.4%) |
| 2 | 17 (11.1%) | |
| 3 | 15 (9.8%) | |
| 5 | 1 (0.7%) |
aOther types of pathology included adenosquamous carcinoma and some NSCLC with a non-clear diagnosis. bSequence 1, patients who received chemotherapy first. cSequence 2, patients who received radiation therapy first. dRP, radiation pneumonitis.